New Immuotherapeutic Approved for Rare Skin Cancer
The U.S. Food and Drug Administration decision makes avelumab the first-ever approved treatment for metastatic Merkel cell carcinoma. The...
Progress Against Cancer
The U.S. Food and Drug Administration decision makes avelumab the first-ever approved treatment for metastatic Merkel cell carcinoma. The...
The FDA has approved the immunotherapeutic pembrolizumab to treat Hodgkin lymphoma. The U.S. Food and Drug Administration (FDA) recently...
The FDA approved a molecularly targeted therapeutic for postmenopausal women with HR-positive, HER2-negative breast cancer. The U.S. Food and...
The U.S. Food and Drug Administration action means ibrutinib is now an approved treatment for three types of non-Hodgkin...
The U.S. Food and Drug Administration decision means nivolumab is now an approved treatment for six types of cancer....
The newly approved therapeutic is for treating women whose cancers test positive for BRCA1 and BRCA2 mutations with a...
The U.S. Food and Drug Administration decision means nivolumab is now an approved treatment for five types of cancer....
Adding the newly approved therapeutic to standard treatment improved survival for patients with advanced disease. The U.S. Food and...
The U.S. Food and Drug Administration approval means there are now three immunotherapeutics called checkpoint inhibitors approved for treating...
The U.S. Food and Drug Administration approval provides a new treatment option for patients with the most common type...